Unknown

Dataset Information

0

Chromothripsis as an on-target consequence of CRISPR-Cas9 genome editing.


ABSTRACT: Genome editing has therapeutic potential for treating genetic diseases and cancer. However, the currently most practicable approaches rely on the generation of DNA double-strand breaks (DSBs), which can give rise to a poorly characterized spectrum of chromosome structural abnormalities. Here, using model cells and single-cell whole-genome sequencing, as well as by editing at a clinically relevant locus in clinically relevant cells, we show that CRISPR-Cas9 editing generates structural defects of the nucleus, micronuclei and chromosome bridges, which initiate a mutational process called chromothripsis. Chromothripsis is extensive chromosome rearrangement restricted to one or a few chromosomes that can cause human congenital disease and cancer. These results demonstrate that chromothripsis is a previously unappreciated on-target consequence of CRISPR-Cas9-generated DSBs. As genome editing is implemented in the clinic, the potential for extensive chromosomal rearrangements should be considered and monitored.

SUBMITTER: Leibowitz ML 

PROVIDER: S-EPMC8192433 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7263196 | biostudies-literature
| S-EPMC4302896 | biostudies-other
| S-EPMC5116081 | biostudies-other
| S-EPMC4978904 | biostudies-other
| S-EPMC4697396 | biostudies-other
| S-EPMC10034092 | biostudies-literature
| S-EPMC4086086 | biostudies-other
| S-EPMC4877446 | biostudies-other
| S-EPMC9341079 | biostudies-literature
| S-EPMC4927198 | biostudies-literature